NAD+ IV Therapy: Benefits, Cost, and What to Expect

NAD+ has become the most talked-about molecule in the anti-aging and longevity community. Podcasts, biohacking conferences, and wellness clinics tout it as a key to reversing cellular aging, boosting mental clarity, fighting addiction, and restoring youthful energy. Some clinics charge over $1,000 for a single infusion, and patients willingly pay it.

The interest shows no signs of cooling off. As of early 2026, the number of clinics offering NAD+ IV therapy across the US has grown substantially, with new clinical trials underway investigating long-term effects and applications for age-related disorders. The longevity medicine community is watching closely as the research pipeline matures.

But NAD+ IV therapy sits at an unusual intersection. The basic biology is real and well-documented. NAD+ levels do decline with age, and this decline is associated with numerous age-related diseases. The question is whether delivering NAD+ through an IV can meaningfully reverse this decline and whether the benefits justify the significant cost.

This guide examines everything you need to know: what NAD+ actually does in your body, what the clinical research shows, what a session feels like, how much it costs, and whether you should consider it.

What Is NAD+ and Why Does It Matter?

The Basics

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It was first discovered in 1906, and over the following century, researchers identified its role in hundreds of critical biological processes.

NAD+ functions primarily as an electron carrier in metabolism. It shuttles electrons between molecules during the chemical reactions that convert food into cellular energy (ATP). Without NAD+, your mitochondria cannot produce energy, and your cells cannot function.

NAD+ Beyond Energy Production

Research over the past two decades has revealed that NAD+ does far more than just help produce energy:

• DNA repair: NAD+ activates enzymes called PARPs (poly ADP-ribose polymerases) that detect and repair damaged DNA. Without adequate NAD+, DNA damage accumulates, contributing to aging and cancer risk.
• Sirtuin activation: NAD+ is required to activate sirtuins, a family of seven proteins that regulate inflammation, stress resistance, fat metabolism, and cellular aging. Sirtuins are sometimes called "longevity proteins" because of their role in extending lifespan in animal studies.
• Circadian rhythm regulation: NAD+ levels naturally fluctuate over a 24-hour cycle and help regulate your body's internal clock, which affects sleep, hormone production, and metabolism.
• Immune function: NAD+ supports immune cell function and helps regulate inflammatory responses.
• Cellular senescence: Emerging research suggests NAD+ plays a role in clearing senescent ("zombie") cells that accumulate with age and drive chronic inflammation. This connection to the senolytic field has generated fresh interest among longevity researchers.

The NAD+ Decline Problem

Here is where the anti-aging interest comes from: NAD+ levels decline significantly as you age. Research published in Cell Metabolism (2019) found that NAD+ levels drop by approximately 50% between ages 40 and 60. This decline correlates with the onset of many age-related conditions:

• Reduced mitochondrial function and energy production
• Impaired DNA repair capacity
• Increased inflammation (sometimes called "inflammaging")
• Decreased sirtuin activity
• Metabolic dysfunction and insulin resistance
• Cognitive decline and neurodegeneration

Animal studies have been dramatic. Research from Harvard's David Sinclair Lab showed that boosting NAD+ levels in old mice restored markers of aging to levels comparable to young mice. A 2013 study published in Cell found that raising NAD+ levels in 22-month-old mice (equivalent to roughly 60-year-old humans) restored mitochondrial function to levels seen in 6-month-old mice within just one week. Subsequent animal research over the past 15 years has consistently shown that mice given NAD+ precursors live longer, maintain better mitochondrial health, and show improved metabolism compared to untreated controls.

The critical caveat: animal results do not automatically translate to humans. And as of 2026, we still do not have outcome data showing extended lifespan or reduced mortality in humans from NAD+ supplementation.

How NAD+ IV Therapy Works

Why IV Delivery?

NAD+ as a molecule is large, unstable, and poorly absorbed through the digestive tract. When taken orally, NAD+ is broken down in the gut before it can reach the bloodstream intact. This is why IV delivery became the preferred administration method for clinics targeting NAD+ supplementation.

IV delivery places NAD+ directly into the bloodstream, bypassing digestive breakdown entirely. However, there is a scientific debate about whether exogenous (externally supplied) NAD+ actually enters cells effectively or whether the body primarily uses precursors like NMN and NR to synthesize NAD+ inside cells.

NAD+ Injections: A Newer Alternative

In 2025 and 2026, NAD+ subcutaneous and intramuscular injections have gained traction as a faster, cheaper alternative to full IV infusions. These injections take just minutes instead of hours and cost $40-$200 per session compared to $250-$1,500 for a full IV drip. The trade-off is a smaller dose per session and potentially less complete absorption. Some clinics now offer at-home injection kits with telemedicine oversight, lowering the barrier to entry for patients who want ongoing NAD+ supplementation without the time commitment of IV sessions.

NAD+ Precursors vs. Direct NAD+

This is an important distinction that many clinics gloss over:

• Direct NAD+ IV: Delivers the NAD+ molecule itself into the bloodstream. The theory is that circulating NAD+ can enter cells and immediately boost intracellular levels.
• NMN (nicotinamide mononucleotide): An NAD+ precursor that cells can convert into NAD+. Available orally and as IV infusion. A 2025 clinical trial in older adults demonstrated that NMN supplementation led to significant improvements in walking speed, muscle strength, and self-reported energy levels, adding important human data to the previously animal-dominated evidence base.
• NR (nicotinamide riboside): Another precursor, available orally (as Niagen) and increasingly as IV infusion. A 2024 clinical study found that IV NR increased NAD+ levels by 20.7% above baseline, and interestingly appeared to boost NAD+ levels more effectively than direct NAD+ infusions.

The precursor debate is ongoing. Some researchers argue that precursors like NMN and NR are more effective because cells need to control their own NAD+ production. Others maintain that direct NAD+ has unique benefits. The honest answer is that the science is not settled, though the 2025 NMN trial results have shifted some opinions in favor of precursor-based approaches.

What Does the Research Actually Show?

Animal Studies (Strong Results)

The animal research on NAD+ supplementation is genuinely impressive:

• Muscle aging reversal (Sinclair Lab, 2013): Old mice given NAD+ boosters showed dramatically improved mitochondrial function within one week
• Cognitive protection (2021 Science): NAD+ supplementation protected against neurodegeneration in mouse models of Alzheimer's disease
• Cardiovascular benefits (2020 Circulation): NAD+ repletion improved cardiac function in aged mice
• Extended lifespan (2016 Cell Metabolism): NAD+ supplementation extended lifespan in mice by approximately 5%
• Metabolic improvements (multiple studies, 2018-2025): Consistent evidence that NAD+ precursors improve glucose metabolism, reduce fat accumulation, and enhance insulin sensitivity in aged rodents

Human Studies (Limited but Growing)

Human clinical research on NAD+ IV therapy specifically has expanded meaningfully since 2024:

• Safety and tolerability: Multiple small studies (2020-2025) have confirmed that NAD+ IV infusions at doses up to 750 mg are generally safe and well-tolerated, with nausea being the most common side effect.
• NAD+ level increase: A 2020 study in Aging Cell confirmed that IV NAD+ supplementation does increase blood NAD+ levels, though the duration and cellular uptake remain uncertain.
• The 2024 NR study: Published results showed that IV nicotinamide riboside raised NAD+ levels by 20.7% above baseline, with the increase detectable for several days after infusion.
• The 2025 NMN trial: A clinical study in older adults found that NMN supplementation produced significant improvements in walking speed, grip strength, and self-reported energy levels. This is one of the first human trials to demonstrate functional physical improvements from NAD+ precursor supplementation.
• Timeline of benefits: Clinical observations across multiple centers suggest most patients notice energy improvement within 24-48 hours of their first infusion, cognitive benefits within 3-5 days, and peak results after 3-5 total sessions over a 2-4 week loading period.
• Addiction treatment: A 2019 pilot study at Springfield Wellness Center treated 60 patients with substance use disorders using NAD+ IV protocols. While patients reported reduced cravings and improved well-being, the study lacked a control group, making it impossible to separate treatment effects from placebo and supportive care.
• Cognitive function: No large-scale human trial has demonstrated cognitive benefits from NAD+ IV therapy, though several studies are underway with results expected in late 2026 and 2027.

What Is Missing

The critical gaps in NAD+ IV research include:

• No large randomized controlled trials (most studies have fewer than 50 participants)
• No long-term safety data for chronic NAD+ IV use beyond 12-18 months
• No confirmed anti-aging benefits in humans (no lifespan extension or mortality reduction data)
• No FDA approval for any specific condition
• No consensus on optimal dosing or frequency
• Limited evidence that IV NAD+ reaches intracellular compartments where it is needed most
• Ongoing clinical trials investigating long-term effects and applications for age-related disorders, with several expected to report results in 2026-2027

NAD+ IV Therapy Cost Breakdown

Per-Session Pricing

NAD+ IV therapy remains among the most expensive IV treatments available. Pricing has remained relatively stable heading into 2026, though increased competition among clinics has brought the low end down slightly in some markets:

NAD+ Injection Pricing (Subcutaneous/IM)

A growing number of clinics now offer NAD+ injections as an alternative to full IV infusions:

Pricing by City

• New York City: $500-$1,500
• Los Angeles: $400-$1,200
• Miami: $400-$1,000
• San Francisco: $500-$1,200
• Chicago: $350-$900
• Austin: $300-$800
• Scottsdale: $350-$900
• Nashville: $300-$750
• Dallas: $300-$850
• Denver: $350-$850

Package and Membership Pricing

Many clinics offer loading protocols (multiple sessions in a short period) and maintenance packages:

• Loading protocol (4-6 sessions over 2 weeks): $1,500-$5,000
• Monthly maintenance sessions: $300-$800/month
• Annual membership programs: $3,000-$8,000/year
• Hybrid plans (IV loading + injection maintenance): $2,000-$4,000/year (a newer option combining initial IV sessions with less expensive ongoing injections)

Why NAD+ Is So Expensive

The high cost is driven by several factors:

• Raw material cost: Pharmaceutical-grade NAD+ powder costs significantly more than standard vitamins
• Infusion duration: NAD+ infusions take 2-4 hours (much longer than a typical 30-60 minute Myers' Cocktail)
• Staff time: The extended infusion requires more nursing supervision
• Dosage: Higher doses mean higher material costs
• Market positioning: NAD+ is positioned as a premium treatment, and demand from the longevity community supports premium pricing
• Compounding pharmacy regulations: Increased regulatory scrutiny on compounding pharmacies in 2025-2026 has affected supply chains and, in some regions, pushed prices higher

NAD+ IV vs. Oral Precursors: A Cost Comparison

For context, oral NAD+ precursors offer a significantly cheaper alternative:

• NMN supplements (oral): $40-$80/month
• NR supplements (Niagen/TRU NIAGEN): $40-$60/month
• NAD+ injections (monthly maintenance): $150-$500/month
• NAD+ IV therapy (monthly): $300-$1,000/month

The cost difference between oral supplements and IV therapy is 5-25x. The question is whether the IV delivery provides proportionally better results, and the current evidence does not confirm that it does. However, the 2024 study showing IV NR outperforming oral NR at raising NAD+ levels suggests that route of administration does matter, even if the clinical significance of that difference remains unclear.

What to Expect During an NAD+ IV Session

Before Your Appointment

Preparation recommendations:

• Eat a light meal 1-2 hours before your appointment (NAD+ infusions on an empty stomach frequently cause nausea)
• Hydrate well in the days leading up to your session
• Avoid alcohol for 24-48 hours before treatment
• Disclose all medications during your intake, particularly if you take blood thinners or cardiac medications
• Plan for time: Block 3-5 hours for your appointment
• Bring entertainment: Many patients bring headphones, a book, or a laptop since the infusion takes several hours

During the Infusion

NAD+ infusions are distinctly different from other IV drips:

1. Medical intake and vitals (10-15 minutes)
2. IV placement (5 minutes)
3. Slow infusion (2-4 hours for 500-1,000 mg doses)
4. Monitoring (ongoing throughout)
5. Post-infusion observation (15-30 minutes)

Why is it so slow? NAD+ must be infused gradually because rapid administration causes significant discomfort. Patients who receive NAD+ too quickly commonly experience chest tightness, abdominal cramping, nausea, and an intense feeling of pressure. These side effects are dose-rate dependent, meaning they improve when the drip rate is reduced.

Common Sensations During NAD+ Infusion

NAD+ infusions produce more noticeable sensations than most other IV drips:

• Chest tightness or pressure (most commonly reported, typically mild)
• Abdominal cramping (common, usually transient)
• Nausea (common, especially in the first session or if infusion rate is too fast)
• Warmth or flushing (mild, similar to other IV treatments)
• Head pressure or mild headache (some patients report this)
• Muscle aching (less common, typically mild)

These sensations are generally manageable and decrease with slower infusion rates. Many patients report that side effects diminish with subsequent sessions as the body adjusts.

After the Infusion

Post-treatment experiences vary, but commonly reported effects include:

• Mental clarity: Many patients describe improved focus and cognitive sharpness within hours to 24-48 hours
• Energy boost: Increased energy levels, sometimes lasting several days to two weeks
• Improved sleep: Better sleep quality the night after treatment (commonly reported)
• Mood improvement: A general sense of well-being
• Mild fatigue: Some people feel tired the day of treatment but improved the following day

Clinical observations from multiple wellness centers suggest that peak benefits typically emerge after 3-5 sessions over a 2-4 week loading period, rather than from a single session alone.

Potential Benefits of NAD+ IV Therapy

Energy and Mitochondrial Function

The theory: NAD+ is essential for mitochondrial energy production. Restoring depleted NAD+ levels should improve cellular energy output.

The evidence: Animal studies consistently show improved mitochondrial function with NAD+ supplementation. The 2025 NMN trial provided the first rigorous human data showing measurable improvements in physical energy and muscle performance in older adults. For IV NAD+ specifically, evidence remains limited to patient self-reports and small observational studies. No placebo-controlled trial has confirmed energy benefits in humans from NAD+ IV therapy alone.

Verdict: Plausible mechanism with growing human data for NAD+ precursors, though IV-specific evidence is still limited.

Cognitive Function and Brain Health

The theory: The brain consumes roughly 20% of the body's energy despite being only 2% of body weight. NAD+ decline may disproportionately affect brain function.

The evidence: Animal studies show neuroprotective effects. A 2021 study in Science demonstrated that NAD+ repletion protected against neurodegeneration in mice. Human data is limited to patient reports of improved focus and clarity, typically emerging within 3-5 days of initial treatment. Several clinical trials investigating cognitive outcomes are expected to report results in late 2026 and 2027.

Verdict: Promising preclinical data, but no confirmed human cognitive benefits from IV NAD+. Results from ongoing trials could change this picture.

Anti-Aging and Longevity

The theory: NAD+ activates sirtuins, supports DNA repair, and maintains mitochondrial function, all of which are central to the aging process.

The evidence: This is the area generating the most scientific interest. The 2013 Sinclair Lab study showing age reversal in mice was a landmark finding. Over 15 years of subsequent animal research has consistently demonstrated that NAD+ precursors extend lifespan, improve mitochondrial health, and enhance metabolism in rodents. However, no human study has demonstrated measurable age reversal or lifespan extension from NAD+ supplementation. Biomarker studies are underway but definitive results remain pending.

Verdict: The most exciting potential application, but entirely unproven in humans as of 2026.

Addiction Recovery Support

The theory: Substance abuse depletes NAD+ levels, and restoring them may reduce cravings and support recovery.

The evidence: NAD+ IV therapy has been used in addiction treatment since the 1960s, when it was pioneered by Dr. Paul O'Hollaren. The Springfield Wellness Center pilot study (2019) treated 60 patients and reported reduced cravings, but without a control group. Several clinics specializing in addiction recovery incorporate NAD+ protocols, but no randomized trial has confirmed efficacy. Some practitioners have reported promising results combining NAD+ IV with behavioral therapy, though this remains anecdotal.

Verdict: Interesting historical use case with some clinical support, but lacking rigorous evidence.

Athletic Recovery

The theory: Intense exercise depletes NAD+ and increases oxidative stress. Replenishing NAD+ could accelerate recovery.

The evidence: Minimal. A few small studies suggest NAD+ precursors may reduce exercise-induced inflammation, but no study has specifically evaluated NAD+ IV therapy for athletic recovery. The 2025 NMN trial showing improved muscle strength in older adults has sparked interest in whether similar benefits could apply to athletic populations, but dedicated trials have not yet been conducted.

Verdict: Theoretical benefit with almost no supporting evidence specific to athletic recovery.

Safety and Side Effects

Generally Recognized Side Effects

• Nausea (most common, affects roughly 20-30% of patients)
• Chest tightness (common during infusion, resolves after)
• Abdominal discomfort (common, usually mild)
• Headache (less common, usually mild)
• Flushing and warmth (common, temporary)
• Fatigue on day of treatment (some patients)

Potential Risks

• Phlebitis (vein inflammation from prolonged infusion)
• Infection (standard risk with any IV procedure)
• Unknown long-term effects (no studies beyond 12-18 months of regular use)
• Drug interactions (NAD+ may interact with certain medications; always disclose your medications)
• Cardiovascular effects (rapid infusion can cause heart rhythm changes; proper administration is essential)
• Compounding quality variability: As demand has grown, so has the number of compounding pharmacies producing NAD+ for infusion. Quality control varies, and patients should confirm their clinic sources from a reputable, FDA-registered compounder.

Who Should Avoid NAD+ IV Therapy

• Pregnant or breastfeeding women (no safety data)
• People with active cancer (NAD+ may theoretically support tumor cell energy production, though this is debated and remains an active area of research)
• People with severe kidney or liver disease
• Those taking medications that affect NAD+ metabolism
• Anyone with a history of severe reactions to niacin or niacinamide

NAD+ IV Therapy vs. Alternatives

Oral NMN Supplements

• Cost: $40-$80/month
• Convenience: Daily pill, no clinic visit required
• Evidence: Growing research base, including a 2022 Science study showing NMN improved muscle function in older adults, and a 2025 clinical trial confirming improvements in walking speed, grip strength, and energy in older adults
• Drawback: Lower bioavailability than IV delivery

Oral NR (Niagen) Supplements

• Cost: $40-$60/month
• Convenience: Daily capsule
• Evidence: Several published human trials confirming safety and NAD+ level increase
• Drawback: The 2024 study suggests IV NR may be more effective than oral NR at raising NAD+ levels

NAD+ Injections (Subcutaneous/IM)

• Cost: $40-$200 per session, or $200-$500/month for at-home kits
• Convenience: 5-15 minutes in clinic or self-administered at home
• Evidence: Limited but growing; generally considered to deliver more NAD+ than oral supplements but less than full IV infusion
• Drawback: Smaller dose per session; some patients report injection site soreness

NAD+ Nasal Spray

• Cost: $50-$100/month
• Convenience: Self-administered at home
• Evidence: Very limited; some practitioners recommend it as maintenance between IV sessions
• Drawback: Unproven bioavailability and efficacy

NAD+ Patches (Transdermal)

• Cost: $60-$120/month
• Convenience: Apply and wear for several hours; no needles
• Evidence: Extremely limited; newer delivery method with minimal clinical data
• Drawback: Absorption rates through the skin for a molecule the size of NAD+ are questionable

Lifestyle Interventions That Boost NAD+

Several free or low-cost strategies have been shown to increase NAD+ levels:

• Exercise: Regular aerobic exercise increases NAD+ production via the NAMPT enzyme pathway. This remains the most well-evidenced and cost-effective way to boost NAD+ levels.
• Caloric restriction or intermittent fasting: Well-documented to increase NAD+ levels in both animal and human studies
• Quality sleep: Circadian alignment supports natural NAD+ cycling
• Reducing alcohol consumption: Alcohol directly depletes NAD+ through its metabolism
• Heat exposure (sauna): Preliminary evidence suggests heat stress activates NAD+ production pathways
• Cold exposure: Some research indicates cold stress may activate sirtuins and support NAD+ pathways, though evidence is preliminary

How to Decide If NAD+ IV Therapy Is Right for You

It May Be Worth Considering If:

• You have the financial resources and the cost does not create hardship
• You are experiencing age-related energy decline, cognitive changes, or recovery issues
• You have already optimized sleep, exercise, diet, and stress management
• You want to try it as part of a comprehensive longevity strategy
• You understand that the evidence is preliminary and you are comfortable with that uncertainty
• You have consulted with a physician who understands your full health picture

It Is Probably Not Worth It If:

• The cost would be a significant financial strain
• You are expecting guaranteed or dramatic results
• You have not addressed basic lifestyle factors (sleep, exercise, nutrition)
• You are healthy and under 40 with no specific health concerns
• You are looking for a quick fix rather than a long-term health strategy

A Practical Approach

If you are curious about NAD+ but cautious about the investment:

1. Start with blood work. Some labs can measure NAD+ levels directly, giving you a baseline. This test typically costs $100-$250.
2. Optimize lifestyle factors first. Exercise, sleep, fasting, and reducing alcohol are all free and evidence-backed ways to raise NAD+ levels.
3. Try oral precursors. NMN or NR supplements at $40-$80/month for 3 months can give you a sense of whether NAD+ supplementation makes a noticeable difference. The 2025 NMN trial data supports the potential effectiveness of this approach.
4. Consider injections as a middle ground. At $40-$200 per session, NAD+ injections offer a step up from oral supplements without the time and cost commitment of full IV infusions.
5. If oral precursors or injections help, consider a single IV session to compare the experience.
6. Track subjective metrics (energy, sleep quality, mental clarity, recovery time) before and after using a simple daily journal or health tracking app.
7. Consult a longevity-focused physician who can interpret your results in context and monitor your progress over time.

What to Watch for in 2026 and Beyond

The NAD+ research landscape is evolving rapidly. Several developments are worth tracking:

• Ongoing clinical trials: Multiple studies investigating NAD+ IV therapy for age-related disorders are expected to report results in late 2026 and 2027. These could meaningfully shift the evidence base.
• Combination therapies: Some clinics are experimenting with combining NAD+ infusions with other longevity interventions like rapamycin, metformin, or senolytics. Early protocols exist but no controlled studies have been published.
• Regulatory landscape: Increased FDA scrutiny on compounding pharmacies may affect availability and pricing of NAD+ infusions. Patients should stay informed about the regulatory status in their state.
• Biomarker validation: Researchers are working to identify reliable biomarkers that can predict which patients will respond best to NAD+ supplementation, potentially allowing for more personalized treatment protocols.
• Cost trajectory: As competition increases among clinics and injection-based alternatives grow, the overall cost of NAD+ supplementation is trending downward for maintenance protocols, even as premium IV services hold their pricing.

Frequently Asked Questions

How long do the effects of NAD+ IV therapy last?

Most patients report feeling the effects for 2-14 days after a single infusion, depending on the dosage and their baseline NAD+ levels. The duration varies significantly between individuals. This is why clinics recommend loading protocols (multiple sessions over 1-2 weeks) followed by monthly maintenance. Clinical observations suggest peak benefits emerge after 3-5 sessions over 2-4 weeks.

Is NAD+ IV therapy FDA-approved?

No. NAD+ IV therapy is not FDA-approved for treating any specific condition. The FDA regulates the individual ingredients, but the therapeutic practice of NAD+ infusion in wellness settings is not specifically approved or regulated. This does not make it illegal, but it does mean the treatment has not undergone the rigorous clinical trials required for FDA approval. As of 2026, no pharmaceutical company has announced plans to pursue FDA approval for NAD+ IV therapy, largely because NAD+ cannot be patented.

Can NAD+ IV therapy help with Long COVID?

Some practitioners report using NAD+ IV therapy for Long COVID symptoms, particularly fatigue and brain fog. The theoretical basis is that viral illness may deplete NAD+ and impair mitochondrial function. However, no clinical trial has specifically evaluated NAD+ IV therapy for Long COVID. A few case series have been published with encouraging results, but controlled evidence is lacking. Given the overlap between Long COVID fatigue and mitochondrial dysfunction, this remains an area of active clinical interest.

How is NAD+ IV therapy different from a regular vitamin IV?

NAD+ infusions differ from standard vitamin IVs in several ways: they take significantly longer (2-4 hours vs. 30-60 minutes), cost substantially more ($250-$1,500 vs. $150-$300), produce more noticeable side effects during infusion (chest tightness, nausea), and target a fundamentally different biological pathway (cellular energy and aging vs. nutrient repletion).

At what age should someone consider NAD+ IV therapy?

NAD+ levels begin declining in your 30s and drop more significantly after 40. Most NAD+ IV therapy patients are between 40 and 70 years old. However, there is no consensus on the optimal age to start, and some younger patients with specific concerns (chronic fatigue, addiction recovery, neurological conditions) also seek treatment. The decision should be based on individual health status and goals rather than age alone.

Are NAD+ injections as effective as IV infusions?

This is one of the most common questions in 2026 as injection options have expanded. NAD+ injections deliver a smaller dose per session and absorb more slowly than IV infusions. Some clinicians believe the slower absorption actually causes fewer side effects and may provide a more sustained NAD+ level increase. However, no head-to-head clinical trial has compared IV infusions to subcutaneous or intramuscular injections. Injections are best viewed as a more accessible, affordable maintenance option, while IV infusions may be preferred for initial loading protocols.

Should I take oral NMN or NR instead?

Oral precursors are a reasonable starting point, especially given the 2025 NMN trial showing functional improvements in older adults. They cost a fraction of IV therapy and can be taken daily at home. The trade-off is lower bioavailability. Many longevity physicians recommend starting with oral precursors and escalating to injections or IV therapy only if you want stronger effects and can afford the investment.

Related Reading

• IV Therapy for Hangovers: What Actually Works
• Best Alternatives to IV Therapy: What Else Works [2026]
• IV Therapy Benefits: What the Latest Research Shows [2026]
• IV Therapy Side Effects and Risks: What You Need to Know [2026]
• IV Therapy During Pregnancy: Safety and Considerations

-- The IV Therapy Finder Team